Advertisement

Inflammation Research

, Volume 66, Issue 10, pp 901–910 | Cite as

Effects of sevoflurane on NF-кB and TNF-α expression in renal ischemia–reperfusion diabetic rats

  • Yu Zhang
  • Fang Hu
  • Jianghua Wen
  • Xiaohong Wei
  • Yingjuan Zeng
  • Ying Sun
  • Shunkui Luo
  • Liao SunEmail author
Original Research Paper

Abstract

Background

Ischemia–reperfusion (I/R) injury is the main reason of acute renal failure. However, inflammatory response and cell apoptosis are important mechanisms implicated in I/R injury. Recent studies indicated that nuclear factor kappa B (NF-кB) and tumor necrosis factor α (TNF-α) are both involved in these mechanisms. Sevoflurane reduces NF-кB and TNF-α expression in rats’ heart and decreases their renal I/R injury. However, few studies are available regarding the effect of sevoflurane on kidney of diabetic rats. Therefore, the aim of this study was to evaluate sevoflurane effect on NF-кB and TNF-α expression in diabetic rats to decrease renal I/R injury.

Methods

Male Sprague–Dawley rats were divided into five groups: Group A, non-diabetic rats underwent sham operation; Group B, non-diabetic rats with renal I/R injury; Group C, diabetic rats underwent sham operation; Group D, diabetic rats with renal I/R injury; Group E, diabetic rats with renal I/R injury after sevoflurane pretreatment. Rats of Group E were exposed to 2.5% sevoflurane for 30 min. After 24 h, creatinine (Cr), blood urea nitrogen (BUN), renal cell apoptosis, and NF-кB and TNF-α expression in kidney were assessed.

Results

Renal cell apoptosis, NF-кB, and TNF-α expression were significantly higher in diabetic rats with renal I/R injury group compared to diabetic rats that underwent sham operation (P < 0.01). These changes were significantly reduced by sevoflurane (P < 0.01).

Conclusion

Sevoflurane exerted a protective effect against renal injury by lowering the expression of NF-кB and TNF-α in renal I/R diabetic rats.

Graphical abstract

Keywords

Diabetes mellitus Renal ischemia–reperfusion injury Sevoflurane NF-кB TNF-α 

Notes

Acknowledgements

This research was supported by the Planning Project of Science and Technology of Zhuhai (No. PC2010B04102028).

Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

References

  1. 1.
    Nelson CL, Karschimkus CS, Dragiccvic G, et al. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transpl. 2005;20:2420–6.CrossRefGoogle Scholar
  2. 2.
    Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens. 1997;15:1365–77.CrossRefPubMedGoogle Scholar
  3. 3.
    Katzberg RW, Barrett BJ. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology. 2007;243:622–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Leblanc M, Kellum JA, Noel RT, et al. Risk factors for acute renal failure: inherent and modifiable risks. Curr Opin Crit Care. 2005;11:533–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Melin J, Hellberg O, Akyurek LM, et al. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int. 1997;52:985–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Yuan Q, Hong SJ, Han S, et al. Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress. PLoS One. 2011;6:e25811.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ramires PA, Giuffrida A, Milella E. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. P Natl Acad Sci USA. 2004;101:5634–9.CrossRefGoogle Scholar
  8. 8.
    Dormond O, Madsen JC, Briscoe DM. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem. 2007;282:23679–86.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hepgul N, Cattaneo A, Zunszain PA, et al. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med. 2013;11:28.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Benedetti G, Fokkelman M, Yan K, et al. The nuclear factor kappaB family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin/tumor necrosis factor alpha synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch. Mol Pharmacol. 2013;84:128–38.CrossRefPubMedGoogle Scholar
  11. 11.
    Gao G, Zhang B, Ramesh G, et al. TNF-alpha mediates increased susceptibility to ischemic AKI in diabetes. Am J Physiol-Renal. 2013;304:F515–21.CrossRefGoogle Scholar
  12. 12.
    Casanova J, Garutti I, Simon C, et al. The effects of anesthetic preconditioning with sevoflurane in an experimental lung autotransplant model in pigs. Anesth Analg. 2011;113:742–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Lee HT, Chen SW, Doetschman TC, et al. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway. Am J Physiol-Renal. 2008;295:F128–36.CrossRefGoogle Scholar
  14. 14.
    Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology. 2004;100:540–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Ye Z, Guo QL, Wang E. Delayed neuroprotective effect of sevoflurane on the expression of NF-kappaB following transient focal ischemia-reperfusion in rats(in chinese). J Cent South Univ (Med Sci). 2010;35:262–6.Google Scholar
  16. 16.
    Lee HT, Kim M, Jan M, et al. Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol-Renal. 2006;291:F67–78.CrossRefGoogle Scholar
  17. 17.
    Shao PZ, Wei TL, Lu KY, et al. Effects of sevoflurane pretreatment on renal Src and FAK expression in diabetic rats after renal ischemia/reperfusion injury. Mol Cell Biochem. 2013;384:203–11.CrossRefGoogle Scholar
  18. 18.
    Yao XG, Chen F, Li P, et al. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models. J Ethnopharmacol. 2013;150:285–97.CrossRefPubMedGoogle Scholar
  19. 19.
    Jablonski P, Howden BO, Rae DA, et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35:198–204.CrossRefPubMedGoogle Scholar
  20. 20.
    Ierardi E, Meucci G, Hassan C, et al. Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci. 2008;53:1865–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Szlosarek PW, Balkwill FR. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 2003;4:565–73.CrossRefPubMedGoogle Scholar
  22. 22.
    Bradham CA, Qian T, Streetz K, et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol. 1998;18:6353–64.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mercurio F, Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol. 1999;11:226–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Bio. 2004;5:392–401.CrossRefGoogle Scholar
  25. 25.
    Qiao SG, Xie H, Wang C, et al. Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-kappaB and upregulation of autophagy. J Anesth. 2012;27:251–60.CrossRefPubMedGoogle Scholar
  26. 26.
    Zhu L, Carretero OA, Xu J, et al. Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2. Am J Physiol Heart Circ Physiol. 2015;309:H827–34.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Lee JW, Kim SC, Ko YS, et al. Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-kappaB pathway in ischemia/reperfusion-induced acute kidney injury. Biochem Biophys Res Commun. 2014;44:121–7.Google Scholar
  28. 28.
    Huang RF, Zhou QL, Veeraragoo P, et al. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the gamma-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207–16.CrossRefPubMedGoogle Scholar
  29. 29.
    Adil M, Kandhare AD, Visnagri A, et al. Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α. Renal Fail. 2015;37:1396–407CrossRefGoogle Scholar
  30. 30.
    Navarro JF, Milena FJ, Mora C, et al. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin- converting enzyme inhibition. Kidney Int Suppl. 2005;68:S98–S102CrossRefGoogle Scholar
  31. 31.
    Lampropoulou IT, Stangou M, Papagianni A, et al. TNF-alpha and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:394206.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Adachi T, Sugiyama N, Yagita H, et al. Renal atrophy after ischemia-reperfusion injury depends on massive tubular apoptosis induced by TNF alpha in the later phase. Med Mol Morphol. 2014;47:213–23.CrossRefPubMedGoogle Scholar
  33. 33.
    Dillon CP, Oberst A, Weinlich R, et al. Survival function of the FADD-CASPASE-8- cFLIP (L) complex. Cell Rep. 2012;1:401–7.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sakamaki K, Satou Y. Caspases:evolutionary aspects of their functions in vertebrates. J Fish Biol. 2009;74:727–53.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Wang JK, Wu HF, Zhou H, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury involving mitochondrial ATP-dependent potassium channel and mitochondrial permeability transition pore. Neurol Res. 2015;37:77–83.CrossRefPubMedGoogle Scholar
  36. 36.
    Boost KA, Leipold T. Scheiermann P, etal. Sevoflurane and isoflurane decrease TNF-alpha-induced gene expression in human monocytic THP-1 cells: potential role of intracellular IkappaBalpha regulation. Int J Mol Med. 2009;23:665–71.CrossRefPubMedGoogle Scholar
  37. 37.
    Li XQ, Cao XZ, Wang J, et al. Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats. Mol Brain. 2014;7:69.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Jeong YJ, Kang MJ, Lee SJ, et al. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils. Immunology. 2014;143:269–76.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Zhang YY, Sun MH, Han YW, et al. The saponin DT-13 attenuates tumor necrosis factor-alpha-induced vascular inflammation associated with Src/NF-kB/MAPK pathway modulation. Int J Biol Sci. 2015;11:970–81.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Santos MH, Higuchi Mde L, Tucci PJ, et al. Previous exercise training increases levels of PPAR-α in long-term post-myocardial infarction in rats, which is correlated with better inflammatory response. Clinics (Sao Paulo). 2016;71:163–8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Yu Zhang
    • 1
    • 2
  • Fang Hu
    • 1
  • Jianghua Wen
    • 3
  • Xiaohong Wei
    • 1
  • Yingjuan Zeng
    • 1
  • Ying Sun
    • 1
  • Shunkui Luo
    • 1
  • Liao Sun
    • 1
    Email author
  1. 1.Department of Endocrinology and MetabolismThe Fifth Affiliated Hospital of Sun Yat-sen UniversityZhuhaiChina
  2. 2.Department of DermatologyDongguan Maternal and Child Health HospitalDongguanChina
  3. 3.Department of Health ExaminationJiangmen Central HospitalJiangmenChina

Personalised recommendations